William Schaffner

William Schaffner

Vanderbilt University

H-index: 115

North America-United States

About William Schaffner

William Schaffner, With an exceptional h-index of 115 and a recent h-index of 64 (since 2020), a distinguished researcher at Vanderbilt University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical Outcomes of US Adults Hospitalized for COVID-19 and Influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021–September 2022

Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older

Societal cost of racial pneumococcal disease disparities in US adults aged 50 years or older

Pneumococcal vaccination strategies in 50-year-olds to decrease racial disparities: a US societal perspective cost-effectiveness analysis

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates

Lessons Learned From Implementation of Mpox Surveillance During an Outbreak Response in Tennessee, 2022

Meningococcal Disease in Persons With HIV Reported Through Active Surveillance in the United States, 2009–2019

Respiratory Syncytial Virus Hospitalizations Associated With Social Vulnerability by Census Tract: An Opportunity for Intervention?

William Schaffner Information

University

Position

___

Citations(all)

55822

Citations(since 2020)

18662

Cited By

49100

hIndex(all)

115

hIndex(since 2020)

64

i10Index(all)

453

i10Index(since 2020)

241

Email

University Profile Page

Vanderbilt University

Google Scholar

View Google Scholar Profile

Top articles of William Schaffner

Title

Journal

Author(s)

Publication Date

Clinical Outcomes of US Adults Hospitalized for COVID-19 and Influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021–September 2022

Open Forum Infectious Diseases

Noah Kojima

Christopher A Taylor

Mark W Tenforde

Dawud Ujamaa

Alissa O’Halloran

...

2024/1

Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older

Vaccine

Angela R Wateska

Mary Patricia Nowalk

Chyongchiou J Lin

Lee H Harrison

William Schaffner

...

2023/7/5

Societal cost of racial pneumococcal disease disparities in US adults aged 50 years or older

Applied Health Economics and Health Policy

Shoroq M Altawalbeh

Angela R Wateska

Mary Patricia Nowalk

Chyongchiou J Lin

Lee H Harrison

...

2024/1

Pneumococcal vaccination strategies in 50-year-olds to decrease racial disparities: a US societal perspective cost-effectiveness analysis

Value in Health

Shoroq M Altawalbeh

Angela R Wateska

Mary Patricia Nowalk

Chyongchiou J Lin

Lee H Harrison

...

2024/3/8

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates

Journal of Clinical Microbiology

E Misas

E Seagle

EN Jenkins

M Rajeev

S Hurst

...

2024/2/14

Lessons Learned From Implementation of Mpox Surveillance During an Outbreak Response in Tennessee, 2022

Public Health Reports

Christine M Thomas

Julie Shaffner

Renee Johnson

Caleb Wiedeman

Mary-Margaret A Fill

...

2024/1/24

Meningococcal Disease in Persons With HIV Reported Through Active Surveillance in the United States, 2009–2019

Open Forum Infectious Diseases

Keegan C Rudmann

Gabrielle Cooper

Henju Marjuki

Arthur Reingold

Meghan Barnes

...

2024/1

Respiratory Syncytial Virus Hospitalizations Associated With Social Vulnerability by Census Tract: An Opportunity for Intervention?

Open Forum Infectious Diseases

Christine M Thomas

Rameela Raman

William Schaffner

Tiffanie M Markus

Danielle Ndi

...

2024/5

Codetections of other respiratory viruses among children hospitalized with COVID-19

Pediatrics

Nickolas T Agathis

Kadam Patel

Jennifer Milucky

Christopher A Taylor

Michael Whitaker

...

2023/2/1

Influenza-associated hospitalization rates by race and ethnicity and social vulnerability index, flusurv-NET 2019-20 through 2022-23

APHA 2023 Annual Meeting and Expo

Alissa O'Halloran

Shikha Garg

Dawud Ujamaa

Shua Chai

Pam Daily Kirley

...

2023/11/14

Changes in the incidence of invasive bacterial disease during the COVID-19 pandemic in the United States, 2014–2020

The Journal of Infectious Diseases

Namrata Prasad

Julia Rhodes

Li Deng

Natalie L McCarthy

Heidi L Moline

...

2023/4/1

Risk of acute myocardial infarction among patients with laboratory-confirmed invasive pneumococcal disease: a self-controlled case series study

Clinical Infectious Diseases

Andrew D Wiese

Ed Mitchel

Danielle Ndi

Tiffanie M Markus

H Keipp Talbot

...

2023/6/15

740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020

Open Forum Infectious Diseases

Kelly A Jackson

Sydney Resler

Joelle Nadle

Susan Petit

Kimberly Yousey-Hindes

...

2023/12

Severity of Influenza-Associated Hospitalizations by Influenza Virus Type and Subtype in the United States, 2010─ 2019

Kelsey M Sumner

Svetlana Masalovich

Alissa O’Halloran

Rachel Holstein

Arthur Reingold

...

2023/3/13

1443. Characteristics of nursing homes with higher rates of invasive methicillin-resistant Staphylococcus aureus infections

Open Forum Infectious Diseases

Isaac See

Kelly A Jackson

Rongxia Li

Prabasaj Paul

Kelly M Hatfield

...

2023/12

Factors associated with SARS-CoV-2 and community-onset invasive Staphylococcus aureus coinfection, 2020

Antimicrobial Stewardship & Healthcare Epidemiology

Kelly Jackson

Sydney Resler

Joelle Nadle

Susan Petit

Susan Ray

...

2023/6

Traditional definition of healthcare-associated influenza underestimates cases associated with other healthcare exposures in a population-based surveillance system

Antimicrobial Stewardship & Healthcare Epidemiology

Erin Gettler

Thomas Talbot

H Keipp Talbot

Bryan Harris

Danielle Ndi

...

2021/7

Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019

Influenza and Other Respiratory Viruses

Christina E Parisi

Kimberly Yousey‐Hindes

Rachel Holstein

Alissa O'Halloran

Pam Dailey Kirley

...

2023/1

Influenza antiviral use in patients hospitalized with laboratory-confirmed influenza in the United States, FluSurv-NET, 2015–2019

Open Forum Infectious Diseases

Mark W Tenforde

Charisse N Cummings

Alissa C O’Halloran

Gretchen Rothrock

Pam Daily Kirley

...

2023/1/1

2614. Trends in characteristics of influenza-associated hospitalizations among pregnant women, FluSurv-NET 2015-2016 through 2022-2023 seasons

Open Forum Infectious Diseases

Catherine Bozio

Dawud Ujamaa

Fatimah S Dawood

Shua Chai

Pam Daily Kirley

...

2023/12

See List of Professors in William Schaffner University(Vanderbilt University)